Preclinical Drug Discovery & Development

Gain a comprehensive understanding of preclinical drug discovery and development.  Through the use of lectures, case studies and discussion, this course will cover the framework of the various stages of developing a therapeutic agent including biologics.  This course is appropriate for those without a strong technical background as well as experienced biologists and chemists, who want to gain knowledge into how new drugs are discovered and the processes needed to take them to clinical studies.

Topics include:

• Drug targets, mechanisms and target identification
• Target based drug design and modeling
• Lead generation and optimization
• Cell and animal experimentation
• ADME
• Pharmacokinetics and Pharmacodynamics
• Toxicity, drug safety pharmacology
• Biologic drugs
• Formulations
• Investigational New Drug (IND) filings.

Learning Objectives:

• Understand the different stages of the process of drug discovery and development
• Identify the role played by different disciplines in preclinical drug development
• Appreciate the interplay between business and science in drug discovery
• Be aware of the legal regulations to be thought through to get a drug commercialized
• Analyze case studies that exemplify the modern drug discovery and preclinical processes

Course Number: BIOL-40125
Credit: 3.00 unit(s)

+ Expand All

7/1/2024 - 9/2/2024

$725

Online

Add To Cart

• SECTION ID:

  181245

• CLASS TYPE:

  Online Asynchronous.
  
  This course is entirely web-based and to be completed asynchronously between the published course start and end dates. Synchronous attendance is NOT required.
  You will have access to your online course on the published start date OR 1 business day after your enrollment is confirmed if you enroll on or after the published start date.

• INSTRUCTOR:
  

  Villar, Hugo, President, Altoris, Inc.; Associate Dean, Professional and Continuing Education, UC San Diego Extension

  Hugo Villar is the Dean of the Division of Extended Studies at UC San Diego. He has over 22 years of experience in the life sciences industry and is the president of Altoris, Inc., a local consulting firm focusing on chemoinformatics and molecular modeling, multivariate analysis, discovery informatics and intellectual property and evaluation. Villar specializes in the evaluation and development of technologies for drug discovery. In particular, software applications to problems in the life sciences, with an emphasis in chemistry. He served as the vice president of Chemoproteomics at Triad Therapeutics and vice president of Discovery Technologies at Telik, Inc. Villar has a Ph.D. in chemistry and a MBA (Healthcare and Pharmaceuticals) from the University of Col...Read More

• TEXTBOOKS:

  No information available at this time.

• POLICIES:

  No refunds after: 7/8/2024.
  

• NOTE:

• DATE & LOCATION:

  7/1/2024 - 9/2/2024
  extensioncanvas.ucsd.edu
  You will have access to your course materials on the published start date OR 1 business day after your enrollment is confirmed if you enroll on or after the published start date.